| BD reports "solid" third quarter performance | Posted on 30/07/2009 in Scientific BD has posted "solid" results for its third fiscal quarter, its chairman and chief executive has said.
Edward Ludwig made his comments as the firm reported quarterly revenues of $1.82 billion (1.10 billion pounds) for the three-month period ended June 30th 2009.
While this represented a fall of 1.6 per cent from the same period last year, worldwide revenues increased by five per cent when the unfavourable impact of foreign currency translation is excluded.
Mr Ludwig said: "We are pleased with our solid third quarter performance and, in particular, the results achieved by our diagnostics segment and our medical segment's pharmaceutical systems and diabetes care units."
He concluded by stating that the company exceeded its overall expectations in the quarter, despite an increasingly challenging global economy.
In recent days, the firm's board of directors declared a quarterly dividend of 33 cents per share of common stock, which is payable on September 30th to individuals who are holders of record on September 9th. Other news stories from 30/07/2009
Read more in the Zenopa News Archive
How this news is generated
|  |
|
